ZORBA extra weight loss (Q-Slim) leads to a new and promising second-generation drug candidates for anti-cholesterol lower cholesterol and increase HDL (good cholesterol)

Roanoke, VA (NYSE) 11 December 2005

The participants take

Q-Slim were observed have significantly reduced cholesterol, LDL reduction, reduced triglycerides (blood fats) and higher HDL (good cholesterol). In fact, some participants on Q-Slim, that the study began with normal HDL levels and the average was also moved to the top of the range of HDL, which are classified as? Protection against heart disease? from the American Heart Association, and some participants in the â? Danger? Levels is in the range danger area in the HDL level and much more as usual.

Q-Slim is a weight loss supplement made from natural fibers and nutrients, a powerful, new and innovative (â? premiere of a sponge is ????) technology-all natural fats. While the fiber Q-Slim’s human study data promising results show for the use of Q-Slim as a formulation for a non-prescription fiber supplement to promote heart health and help losing weight, are the most exciting aspects of these results, the proposals even more promise for future changes . second generation of fiber-based technology concepts from Q-Slim is designed pulled expected to provide drug candidates for a major FDA-approved in the cholesterol-lowering drugs.

learned that scientists have ZPRO accelerated the pace of research for a new drug (Compound Z), which should go beyond testing and validation seriously begin pre-clinical FDA next year of testing. As mentioned above, the composition of the second generation, the information that supplements of Q-Slim fiber learned studies was to use. While the drug candidate compound Z, FDA studied a different composition (different chemical structure) than Q-Slim fibers is, and develop concepts from research Q-Slim.

fiber Q-Slim Compound Z has a greatly improved ability to bind to bile acids in the digestive system. Compound Z is expected to keep most of the observed properties of the Q-Slim (lowering total cholesterol while increasing good cholesterol, HDL), but for a different market than weight loss. Z-connection should be much more reduced (many orders of magnitude more) than Q-Slim to total cholesterol. Since compound Z includes the ability to remove large amounts of bile acids from the digestive tract, it uses up excess cholesterol to make new bile acids are stored in the liver preparation.

bile salts (to help digest the fat calories) are usually returned by the body (intestine and liver), but binding digestive bile salts and remove them stored for use by the forces of the digestive system of the body cholesterol to make more bile salts. Compound Z is a new compound which is a candidate drug may also be a greater reduction of cholesterol levels lead to the additional Q-Slim is increased while maintaining the ability of Q-Slim fibers to HDL levels.

Z is not a drug-systemic FDA (a formulation that does its work in the digestive system). Compound Z should eventually be approved as the only prescription formulation on the market with such capabilities in a single connection, multi-faceted (not systemic). No single product has been approved by the FDA currently alleged in a position of total cholesterol are significantly lower, while at the same time the good cholesterol (HDL). Z-connection should be much less effective in complement to the binding of fat and promote weight loss, that Q-Slim fiber.

changes and structural improvements Compound Z (based on Q-Slim supplements) should greatly increase the ability of the compound of Z up to remove bile salts and lower cholesterol, by comparing Q-Slim. Not expected to be negative side effects for compound Z in the required dose. When the compound Z at the height of his early promise, it will be a powerful new formulation that was able to be out of date (many people) the use of systemic inhibitors of the production of cholesterol (statins), often have undesirable side effects. Even people on statins may be able to the amount of statins required to maintain a desirable lower cholesterol levels when they take to Z compounds and the dose of statins.

Q-Slim is a trademark of ZPRO Pharmaceutical, Inc.

The above statements

on the analysis of data and opinions are based by the author, and have not been evaluated by the Food and Drug Administration. Q-Slim is not intended to diagnose, treat or cure a disease. Ask your doctor before starting any weight loss. See website for more information www.azorba.com.

clear = “all”
good cholesterol